Cite

HARVARD Citation

    Ito, K. et al. (2013). Cost‐effectiveness of full coverage of aromatase inhibitors for Medicare beneficiaries with early breast cancer. Cancer. 119 (13), pp. 2494-2502. [Online]. 
  
Back to record